Vanderbilt University - Ingram Cancer Center — Nashville, Tennessee

Vanderbilt University - Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt University - Ingram Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory T Cell Lymphoma, Urothelial Carcinoma, Urothelial Carcinoma Bladder.

Sponsors: Ono Pharmaceutical Co. Ltd, Mirati Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University - Ingram Cancer Center?

Vanderbilt University - Ingram Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University - Ingram Cancer Center conducted?

Vanderbilt University - Ingram Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory T Cell Lymphoma, Urothelial Carcinoma, Urothelial Carcinoma Bladder.

Is Vanderbilt University - Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt University - Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University - Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.